dydrogesterone has been researched along with medroxyprogesterone acetate in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 11 (39.29) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| King, RJ; Whitehead, MI | 1 |
| Boyce, SW; Hoffman, PG; Mathes, SJ | 1 |
| Holland, EF; Smith, RN; Studd, JW; Zamblera, D | 1 |
| Bertinetti, G; Dell'Elce, C; Delzanno, G; Gaudiano, L; Paoletti, R; Ventrella, CA | 1 |
| Gliosci, A; Presutti, F | 1 |
| Battino, S; Ben-Ami, M; Geslevich, Y; Shalev, E; Weiner, E | 1 |
| Gökmen, O; Yapar Eyi, EG | 1 |
| Bland, E; Deary, AJ; Prentice, A | 1 |
| Simon, JA | 1 |
| Ho, KK; Leung, KC; Nugent, AG; Reutens, AT; Sullivan, D | 1 |
| Chang, TC; Chen, M; Chen, RJ; Cheng, SP; Chow, SN; Lien, YR | 1 |
| Franke, HR; Vermes, I; Werner, HM | 1 |
| Baldacci, C; Caruso, A; Fornari, L; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Mannella, P; Scorticati, C; Simoncini, T | 1 |
| Genazzani, AR; Mannella, P; Pluchino, N; Simoncini, T | 1 |
| de Kraker, AT; Kenemans, P; Kroeks, MV; Smolders, RG; van der Mooren, MJ | 1 |
| Akhtar, M; Brown, J; Kives, S | 1 |
| Beranič, N; Rižner, TL | 1 |
| Beranič, N; Lanišnik Rižner, T | 1 |
| Huras, H; Jach, R; Kempisty-Zdebik, E; Ludwin, A; Ludwin, I; Radon-Pokracka, M; Stangel-Wojcikiewicz, K; Wadowska-Jaszczynska, K; Zdebik, A | 1 |
| Akashi, D; Kato, H; Minobe, S; Okamoto, K; Shimada, C; Todo, Y | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Pinhal, MA; Pompei, LM; Silva, VF; Silveira, ER; Steiner, ML; Theodoro, TR | 1 |
| Castiglioni, S; Fent, K; Zhao, Y | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Petri, G; Pinhal, MA; Pompei, LM; Steiner, ML; Theodoro, TR | 1 |
| Ai, A; Chang, HY; Gao, H; Kuang, Y; Liu, Y; Long, H; Lyu, Q; Quan, X; Yu, S; Zhu, J | 1 |
| Cai, R; Gao, H; Huang, J; Kuang, Y; Lin, J; Lu, X; Xie, Q; Zhu, J | 1 |
| Berkkanoglu, M; Bulut, H; Coetzee, K; Donmez, L; Ozgur, K; Tore, H | 1 |
| Jing, M; Lin, C; Tu, X; You, B; Zhang, R | 1 |
4 review(s) available for dydrogesterone and medroxyprogesterone acetate
| Article | Year |
|---|---|
Progestagens and anti-progestagens for pain associated with endometriosis.
Topics: Dydrogesterone; Endometriosis; Female; Gestrinone; Humans; Medroxyprogesterone Acetate; Pain; Progesterone Congeners; Progestins | 2000 |
Progestogens in the treatment of secondary amenorrhea.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Amenorrhea; Dydrogesterone; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Premenopause; Progesterone; Progesterone Congeners; Progestins | 1999 |
Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels.
Topics: Animals; Cardiovascular System; Central Nervous System; Dydrogesterone; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Progesterone Congeners | 2007 |
Progestagens and anti-progestagens for pain associated with endometriosis.
Topics: Danazol; Dydrogesterone; Endometriosis; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Pelvic Pain; Progesterone Congeners; Progestins | 2012 |
7 trial(s) available for dydrogesterone and medroxyprogesterone acetate
| Article | Year |
|---|---|
A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome.
Topics: Administration, Cutaneous; Adult; Cross-Sectional Studies; Drug Administration Schedule; Dydrogesterone; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Ovulation; Patient Satisfaction; Premenstrual Syndrome; Progestins; Prospective Studies; Treatment Outcome | 1995 |
[Dihydrogesterone vs. medroxyprogesterone acetate in association with transdermal estradiol in postmenopausal substitution treatment].
Topics: Administration, Cutaneous; Bone Density; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal | 1994 |
Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea.
Topics: Administration, Oral; Adolescent; Adult; Amenorrhea; Cohort Studies; Double-Blind Method; Dydrogesterone; Endometrium; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menstruation; Menstruation-Inducing Agents; Middle Aged; Oligomenorrhea; Patient Selection; Progesterone; Progesterone Congeners; Triglycerides; Ultrasonography | 1996 |
Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Topics: Analysis of Variance; Carrier Proteins; Cyproterone Acetate; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin-Like Growth Factor I; Lipids; Liver; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Postmenopause; Progestins; Sex Hormone-Binding Globulin | 2003 |
Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Topics: Antithrombin III; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Dydrogesterone; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Prothrombin Time; Risk Factors; Triglycerides | 2004 |
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
Topics: Adult; alpha-2-Antiplasmin; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Homocysteine; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Time Factors; Tissue Plasminogen Activator | 2009 |
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Topics: Adult; Dydrogesterone; Embryo Transfer; Female; Fertilization in Vitro; Hormones; Humans; Infertility, Female; Medroxyprogesterone Acetate; Menotropins; Ovarian Follicle; Ovulation Induction; Pregnancy; Pregnancy Outcome; Progestins; Prospective Studies; Sperm Injections, Intracytoplasmic | 2018 |
17 other study(ies) available for dydrogesterone and medroxyprogesterone acetate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
Recurrent macromastia after subcutaneous mastectomy.
Topics: Adult; Breast; Breast Diseases; Combined Modality Therapy; Dydrogesterone; Female; Humans; Hypertrophy; Immunosuppressive Agents; Mastectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Recurrence; Reoperation; Surgery, Plastic; Tamoxifen | 1984 |
Virginal gigantomastia: validity of combined surgical and hormonal treatments.
Topics: Adolescent; Adult; Breast Diseases; Combined Modality Therapy; Dydrogesterone; Female; Follow-Up Studies; Gigantism; Humans; Mammaplasty; Medroxyprogesterone Acetate; Nipples; Puberty; Treatment Outcome | 1993 |
Hormone replacement therapy and lipid-lipoprotein concentrations.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dydrogesterone; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins; Longitudinal Studies; Medroxyprogesterone Acetate; Menopause, Premature; Middle Aged; Ovariectomy; Postmenopause; Progesterone Congeners; Prospective Studies; Triglycerides | 1999 |
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2005 |
Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Dydrogesterone; Endothelial Cells; Enzyme Activation; Estradiol; Humans; Medroxyprogesterone Acetate; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type III; Progesterone; Progestins; Transcription, Genetic | 2006 |
Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line.
Topics: Aromatase; Cell Line; Cell Membrane; Cell Nucleus; Dydrogesterone; Endometriosis; Epithelial Cells; Estradiol; Estradiol Dehydrogenases; Estrogen Receptor alpha; Female; Gene Expression Regulation, Enzymologic; Humans; Medroxyprogesterone Acetate; Nandrolone; Progestins; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2012 |
Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aldo-Keto Reductase Family 1 Member C3; Cells, Cultured; Down-Regulation; Dydrogesterone; Endometriosis; Endometrium; Epithelial Cells; Estradiol Dehydrogenases; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Progesterone; Progestins; Receptors, Progesterone; RNA, Messenger | 2013 |
Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels.
Topics: Adolescent; Adult; Chemoradiotherapy; Contraceptive Agents, Female; Drug Combinations; Dydrogesterone; Estradiol; Estriol; Female; Follicle Stimulating Hormone, Human; Hematologic Neoplasms; Hormone Replacement Therapy; Humans; Infertility, Female; Luteinizing Hormone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Ovarian Follicle; Primary Ovarian Insufficiency; Progesterone; Progesterone Congeners; Young Adult | 2012 |
Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report.
Topics: Antineoplastic Agents, Hormonal; Drug Administration Schedule; Dydrogesterone; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progestins; Quality of Life; Sarcoma, Endometrial Stromal; Treatment Outcome | 2013 |
Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone?
Topics: Animals; Biomarkers; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Extracellular Matrix; Female; Glucuronidase; Heparan Sulfate Proteoglycans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction | 2015 |
Synthetic progestins medroxyprogesterone acetate and dydrogesterone and their binary mixtures adversely affect reproduction and lead to histological and transcriptional alterations in zebrafish (Danio rerio).
Topics: Animals; Dose-Response Relationship, Drug; Dydrogesterone; Female; Gene Expression Regulation; Male; Medroxyprogesterone Acetate; Ovary; Random Allocation; Reproduction; Testis; Water Pollutants, Chemical; Zebrafish | 2015 |
Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis.
Topics: Animals; Apoptosis; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Random Allocation; Rats; Rats, Wistar | 2015 |
Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.
Topics: Adult; Cohort Studies; Dydrogesterone; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Medroxyprogesterone Acetate; Ovulation Induction; Polycystic Ovary Syndrome; Progestins; Retrospective Studies; Young Adult | 2019 |
Dydrogesterone versus medroxyprogesterone acetate co-treatment ovarian stimulation for IVF: a matched cohort study of 236 freeze-all-IVF cycles.
Topics: Cohort Studies; Dydrogesterone; Female; Fertilization in Vitro; Humans; Medroxyprogesterone Acetate; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies | 2022 |
Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Topics: Adult; Chorionic Gonadotropin; Clomiphene; Cohort Studies; Dydrogesterone; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Letrozole; Live Birth; Maternal Age; Medroxyprogesterone Acetate; Menotropins; Odds Ratio; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovarian Reserve; Ovulation Induction; Pregnancy; Pregnancy Rate; Progestins; Retrospective Studies; Sperm Injections, Intracytoplasmic; Triptorelin Pamoate | 2021 |